17 results for author:"Meduri G." in Literature citations
Results Customize
› Repeat search in UniProtKB (4)
| Lack of renal 11 beta-hydroxysteroid dehydrogenase type 2 at birth, a targeted temporal window for neonatal glucocorticoid action in human and mice. Martinerie L., Pussard E., Meduri G., Delezoide A.L., Boileau P., Lombes M. PLoS ONE 7:e31949-e31949(2012) · Mapped (4) |
| Mineralocorticoid receptor overexpression facilitates differentiation and promotes survival of embryonic stem cell-derived neurons. Munier M., Law F., Meduri G., Le Menuet D., Lombes M. Endocrinology 153:1330-1340(2012) · Mapped (6) |
| Normosmic congenital hypogonadotropic hypogonadism due to TAC3/TACR3 mutations: characterization of neuroendocrine phenotypes and novel mutations. Francou B., Bouligand J., Voican A., Amazit L., Trabado S., Fagart J., Meduri G., Brailly-Tabard S., Chanson P., Lecomte P. et al. PLoS ONE 6:e25614-e25614(2011) · Mapped (3) |
| Aldosterone postnatally, but not at birth, is required for optimal induction of renal mineralocorticoid receptor expression and sodium reabsorption. Martinerie L., Viengchareun S., Meduri G., Kim H.S., Luther J.M., Lombes M. Endocrinology 152:2483-2491(2011) · Mapped (2) |
| Inter-individual variability of plasma PAF-acetylhydrolase activity in ARDS patients and PAFAH genotype. Li S., Stuart L., Zhang Y., Meduri G.U., Umberger R., Yates C.R. J Clin Pharm Ther 34:447-455(2009) · Mapped (4) |
| Low renal mineralocorticoid receptor expression at birth contributes to partial aldosterone resistance in neonates. Martinerie L., Viengchareun S., Delezoide A.L., Jaubert F., Sinico M., Prevot S., Boileau P., Meduri G., Lombes M. Endocrinology 150:4414-4424(2009) · Mapped (44) |
| Evaluation of different markers of the ovarian reserve in patients presenting with premature ovarian failure. Massin N., Meduri G., Bachelot A., Misrahi M., Kuttenn F., Touraine P. Mol. Cell. Endocrinol. 282:95-100(2008) · Mapped (1) |
| Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations. Gao L., Flores C., Fan-Ma S., Miller E.J., Moitra J., Moreno L., Wadgaonkar R., Simon B., Brower R., Sevransky J. et al. Transl Res 150:18-29(2007) · Mapped (1) |
| Biochemical characterization and modulation of LH/CG-receptor during human trophoblast differentiation. Pidoux G., Gerbaud P., Tsatsaris V., Marpeau O., Ferreira F., Meduri G., Guibourdenche J., Badet J., Evain-Brion D., Frendo J.L. J. Cell. Physiol. 212:26-35(2007) · Mapped (3) |
| Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcription. Georgiakaki M., Chabbert-Buffet N., Dasen B., Meduri G., Wenk S., Rajhi L., Amazit L., Chauchereau A., Burger C.W., Blok L.J. et al. Mol. Endocrinol. 20:2122-2140(2006) · Mapped (9) |
| Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Gao L., Grant A., Halder I., Brower R., Sevransky J., Maloney J.P., Moss M., Shanholtz C., Yates C.R., Meduri G.U. et al. Am. J. Respir. Cell Mol. Biol. 34:487-495(2006) · Mapped (13) |
| Thyrotropin receptor trafficking relies on the hScrib-betaPIX-GIT1-ARF6 pathway. Lahuna O., Quellari M., Achard C., Nola S., Meduri G., Navarro C., Vitale N., Borg J.-P., Misrahi M. |
| Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies. Meduri G., Touraine P., Beau I., Lahuna O., Desroches A., Vacher-Lavenu M.C., Kuttenn F., Misrahi M. J. Clin. Endocrinol. Metab. 88:3491-3498(2003) · UniProtKB (1) |
| A dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus. Ancelin M., Buteau-Lozano H., Meduri G., Osborne-Pellegrin M., Sordello S., Plouet J., Perrot-Applanat M. Proc. Natl. Acad. Sci. U.S.A. 99:6023-6028(2002) · Mapped (6) |
| New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. Touraine P., Beau I., Gougeon A., Meduri G., Desroches A., Pichard C., Detoeuf M., Paniel B., Prieur M., Zorn J.-R. et al. Mol. Endocrinol. 13:1844-1854(1999) · UniProtKB (1) |
| A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. Beau I., Touraine P., Meduri G., Gougeon A., Desroches A., Matuchansky C., Milgrom E., Kuttenn F., Misrahi M. J. Clin. Invest. 102:1352-1359(1998) · UniProtKB (1) |
| Comparison of immunocytochemical and molecular features with the phenotype in a case of incomplete male pseudohermaphroditism associated with a mutation of the luteinizing hormone receptor. Misrahi M., Meduri G., Pissard S., Bouvattier C., Beau I., Loosfelt H., Jolivet A., Rappaport R., Milgrom E., Bougneres P. J. Clin. Endocrinol. Metab. 82:2159-2165(1997) · UniProtKB (1) |